Search

everythinglearnresearchcommunity

for

Search:↓

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

Oral testosterone therapy raises heart risk more than other methods.

Vitamin A toxicity likely caused the patient's high calcium levels.

Older patients sticking to their prostate medication saw lasting health benefits.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Provenge extends prostate cancer survival by about 4 months.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.